455 related articles for article (PubMed ID: 23955585)
21. FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
Hebbar M; Chibaudel B; André T; Mineur L; Smith D; Louvet C; Dutel JL; Ychou M; Legoux JL; Mabro M; Faroux R; Auby D; Brusquant D; Khalil A; Truant S; Hadengue A; Dalban C; Gayet B; Paye F; Pruvot FR; Bonnetain F; Landi B; Flesch M; Carola E; Martin P; Vaillant E; de Gramont A;
Ann Oncol; 2015 Feb; 26(2):340-7. PubMed ID: 25403578
[TBL] [Abstract][Full Text] [Related]
22. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
[TBL] [Abstract][Full Text] [Related]
23. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
24. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer metastases: surgical indications and multimodal approach.
Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
[TBL] [Abstract][Full Text] [Related]
26. Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study).
Beppu T; Emi Y; Tokunaga S; Oki E; Shirabe K; Ueno S; Kuramoto M; Kabashima A; Takahashi I; Samura H; Eguchi S; Akagi Y; Natsugoe S; Ogata Y; Kakeji Y; Baba H; Maehara Y;
Anticancer Res; 2014 Nov; 34(11):6655-62. PubMed ID: 25368271
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
28. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
[TBL] [Abstract][Full Text] [Related]
29. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
Liersch T; Meller J; Kulle B; Behr TM; Markus P; Langer C; Ghadimi BM; Wegener WA; Kovacs J; Horak ID; Becker H; Goldenberg DM
J Clin Oncol; 2005 Sep; 23(27):6763-70. PubMed ID: 16170184
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
33. Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study.
Hirata K; Nagata N; Kato T; Okuyama Y; Andoh H; Takahashi K; Oba K; Sakamoto J; Hazama S; Mishima H
Anticancer Res; 2014 Jan; 34(1):195-201. PubMed ID: 24403462
[TBL] [Abstract][Full Text] [Related]
34. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases.
Beppu T; Hayashi N; Masuda T; Komori H; Horino K; Hayashi H; Okabe H; Baba Y; Kinoshita K; Akira C; Watanebe M; Takamori H; Baba H
Anticancer Res; 2010 Mar; 30(3):1015-20. PubMed ID: 20393029
[TBL] [Abstract][Full Text] [Related]
35. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
[TBL] [Abstract][Full Text] [Related]
36. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
37. [Hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: a phase II trial].
Strobel O; Büchler MW
Chirurg; 2014 Jul; 85(7):641. PubMed ID: 24934110
[No Abstract] [Full Text] [Related]
38. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
39. [Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy].
Brouquet A; Benoist S
Bull Cancer; 2011 Jan; 98(1):11-8. PubMed ID: 21300602
[TBL] [Abstract][Full Text] [Related]
40. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
